Doximity sees artificial intelligence as a major tailwind for the company just six months after acquiring Pathway Medical to ...
Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to streamline trial workflows and reduce operational burden, while also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results